FDA waiting for more data before authorizing Moderna, Pfizer fourth booster dose

DELMARVA — Pfizer and Moderna recently asked the Food and Drug Administration to authorize another booster dose.

Pfizer asked the FDA to authorize fourth doses for people older than 65 and Moderna asked for authorization for everyone 18 and older. A doctor from Atlantic General Hospital said while these requests have been made the FDA is taking their time with this because they feel it’s important to get good data before authorization.

“We don’t want to boost people to just boost people,” Dr. Sally Dowling, VP of Medical Affairs, said. “We want to make sure it’s indicated that there’s significant data there that shows it’s effective and if it is effective what should that time frame be after their third dose until they get any additional doses.”

Dr. Dowling said right now these doses are only approved for those who have significant immune-suppression.

An FDA advisory committee is supposed to discuss booster shots broadly on April 6th.

Categories: Coronavirus, Delaware, Local News, Maryland